The U.S. is reportedly investigating Germany for making medicine and healthcare "too affordable." Germany is being pressured to raise prices, to "prevent" the value of global drug prices from going down. This is what pharma-captured foreign policy looks like: America weaponizing trade investigations to protect drug company profit margins at the expense of human life.